Age, lesion site influence Mohs use for nonmelanoma skin cancers

04/18/2012 | HealthDay News

The use of both Mohs surgery and surgical excision to treat nonmelanoma skin cancer rose from 2001 to 2006, according to a study of nearly 27,000 Medicare patients. Mohs surgery was most likely to be the choice to remove lesions on the lip and eyelid, and to treat younger patients, the researchers found.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX